Sample: financebench_open_source_line_87
Protocol: minions
Timestamp: 2026-01-17T01:34:51.059119
Execution time: 95.71s
Cost: $0.0282
Is correct: None
Error: None

--- Question ---
What drove gross margin change as of FY2022 for JnJ? If gross margin is not a useful metric for a company like this, then please state that and explain why.

--- Predicted Answer ---
The gross margin for JnJ improved from a negative 5.0% in FY2021 to 6.7% in FY2022, driven by increased costs from COVID-19 related expenses and inflation, offset by strategic cost reductions.

--- Ground Truth ---
['For FY22, JnJ had changes in gross margin due to: One-time COVID-19 vaccine manufacturing exit related costs, Currency impacts in the Pharmaceutical segment, Commodity inflation in the MedTech and Consumer Health segments, partially offset by Supply chain benefits in the Consumer Health segment.']